References
1. Ametov A.S. Obesity. A modern view of pathogenesis and therapy: a tutorial. Moscow: GЕОТАR-Media, 2019; (1): 384 p. (in Russian)
2. Sharafetdinov Kh.Kh., Plotnikova O.A. Obesity as a global challenge of the 21st century: clinical medical nutrition, prevention and therapy. Voprosy pitaniia [Problems of Nutrition]. 2020; 89 (4): 161–71. DOI: https://doi.org/10.24411/0042-8833-2020-10050 (in Russian)
3. Seravalle G., Grassi G. Obesity and hypertension. Pharmacol Res. 2017; 122: 1–7. DOI: https://doi.org/10.1016/j.phrs.2017.05.013
4. Bray G.A., Kim K.K., Wilding J.P.H. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017; 18 (7): 715–23. DOI: https://doi.org/10.1111/obr.12551
5. Hales C.M., Carroll M.D., Fryar C.D., Ogden C.L. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief, No. 360. Hyattsville, MD: National Center for Health Statistics. 2020. URL: https://www.cdc.gov/nchs/data/databriefs/db360-h.pdf
6. Balanova Yu.A., Shal’nova S.A., Deev А.D., et al. Obesity in the Russian population – prevalence and associations with risk factors for chronic non-communicable diseases. Rossiyskiy kardiologicheskiy zhurnal [Russian Journal of Cardiology]. 2018; 23 (6): 123–30. DOI: https://doi.org/10.15829/1560-4071-2018-6-123-130 (in Russian)
7. Tino S., Mayanja B.N., Mubiru M.C., Eling E., et al. Prevalence and factors associated with overweight and obesity among patients with type 2 diabetes mellitus in Uganda – a descriptive retrospective study. BMJ Open. 2020; 10 (11): e039258. DOI: https://doi.org/10.1136/bmjopen-2020-039258
8. Kachur S., Lavie C.J., de Schutter A., et al. Obesity and cardiovascular diseases. Minerva Med. 2017; 108 (3): 212–28. DOI: https://doi.org/10.23736/S0026-4806.17.05022-4
9. Owen C.G., Kapetanakis V.V., Rudnicka A.R., et al. Body mass index in early and middle adult life: prospective associations with myocardial infarction, stroke and diabetes over a 30-year period: the British Regional Heart Study. BMJ Open. 2015; 5 (9): e008105. DOI: https://doi.org/10.1136/bmjopen-2015-008105
10. Joshy G., Korda R.J., Attia J., et al. Body mass index and incident hospitalisation for cardiovascular disease in 158 546 participants from the 45 and Up Study. Int J Obes (Lond). 2014; 38 (6): 848–56. DOI: https://doi.org/10.1038/ijo.2013.192
11. Leszczak J., Czenczek-Lewandowska E., Przysada G., et al. Association between body mass index and results of rehabilitation in patients after stroke: a 3-month observational follow-up study. Med Sci Monit. 2019; 25: 4869–76. DOI: https://doi.org/10.12659/MSM.915586
12. Ackerman I.N., Bohensky M.A., Zomer E., et al. The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030. BMC Musculoskelet Disord. 2019; 20 (1): 90. DOI: https://doi.org/10.1186/s12891-019-2411-9
13. Lin C.Y., Shih T.S., Liou S.H., et al. Predictors for progression of sleep disordered breathing among public transport drivers: a 3-year follow-up study. J Clin Sleep Med. 2015; 11 (4): 419–25. DOI: https://doi.org/10.5664/jcsm.4596
14. Patro M., Gothi D., Ojha U.C., et al. Predictors of obesity hypoventilation syndrome among patients with sleep-disordered breathing in India. Lung India. 2019; 36 (6): 499–505. DOI: https://doi.org/10.4103/lungindia.lungindia_61_19
15. Avgerinos K.I., Spyrou N., Mantzoros C.S., Dalamaga M. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism. 2019; 92: 121–35. DOI: https://doi.org/10.1016/j.metabol.2018.11.001
16. Arnold M., Pandeya N., Byrnes G., et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015; 16 (1): 36–46. DOI: https://doi.org/10.1016/S1470-2045(14)71123-4
17. WHO. 2015 Obesity and overweight. Geneva: World Health Organization, 2015. URL: http://www.who.int/mediacentre/factsheets/fs311/en/
18. Cheskin L.J., Poddar K.H. Obesity management. In: A. Catharine Ross et al. (eds). Modern Nutrition in Health and Disease. 11th. Lippincott Williams and Wilkins; Wolters Kluwer, 2014: 786–99.
19. Ge L., Sadeghirad B., Ball G.D.C., et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ. 2020; 369: m696. DOI: https://doi.org/10.1136/bmj.m696
20. Jensen M.D., Ryan D.H., Apovian C.M., et al. 2013 AHA/ACC/TOS Guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014; 63 (25 Pt B): 2985–3023. DOI: https://doi.org/10.1016/j.jacc.2013.11.004
21. EFSA Panel on Dietetic Products, Nutrition and Allergies. Glucomannan related health claims. EFSA J. 2010; 8 (10): 1798.
22. EFSA Panel on Dietetic Products, Nutrition and Allergies. Essential composition of total diet replacements for weight control. EFSA J. 2015; 13 (1): 3957.
23. Zhernakova Yu.V., Zheleznova E.A., Chazova I.E., et al. The prevalence of abdominal obesity in the constituent entities of the Russian Federation and its relationship with socio-economic status, the results of the ESSE-RF epidemiological study. Terapevticheskiy arkhiv [Therapeutic Archive]. 2018; 90 (10): 14–22. DOI: https://doi.org/10.26442/terarkh2018901014-22 (in Russian)
24. Rakel D. Integrative Medicine. E-Book. Elsevier Health Sciences, 2017.